Invex Therapeutics aims to re-purpose a diabetic drug for brain disorders such as idiopathic intracranial hypertension, traumatic brain injury and acute stroke. As the product is already in production and use there is an easy route to entry.
Sector: Healthcare
Industry: Pharmaceuticals
Supply is being soaked and the price has been slowly appreciating due to accumulation.
BioTech sector with Top 20 holding 80%
Market Cap $44m
Cash Rich (Circa $10m)
IPO at 0.40
Quality Management
Price reversal upwardly trending price
Sector: Healthcare
Industry: Pharmaceuticals
Supply is being soaked and the price has been slowly appreciating due to accumulation.
BioTech sector with Top 20 holding 80%
Market Cap $44m
Cash Rich (Circa $10m)
IPO at 0.40
Quality Management
Price reversal upwardly trending price
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.